Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bazzan ( Padova, Italy), C. Radu ( Padova, Italy), G. Turato ( Padova, Italy), M. Tinè ( Padova, Italy), D. Biondini ( Padova, Italy), M. Damin ( Padova, Italy), P. Simioni ( Padova, Italy), M. Cosio (Montreal, Canada), M. Saetta ( Padova, Italy). Characterization of Microparticles in the lung of smokers. 4237

Member's Comments

No comment yet.

Related content which might interest you: Cell-derived microparticles and the lung Source: Eur Respir Rev 2016; 25: 266-277 Year: 2016 Characterization of cellular and biochemical profiles of induced sputum from the hard-core smokers, not suffering from COPD Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Characterization of lung volumes in COPD Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Primary adenocarcinoma of the lung in smokers and never smokers Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004 Characterization of lymphocyte subsets in the lungs of smokers and patients with COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011 Comparative characteristics of lung cancer in smokers and nonsmokers Source: Eur Respir J 2001; 18: Suppl. 33, 115s Year: 2001 Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Lung cancer in passive smokers Source: International Congress 2014 – Pulmonary disorders associated with passive smoking: new online ERS resources Year: 2014 Evaluation of mitochondrial dysfunction of mononuclear leukocytes of smokers and ex-smokers in COPD exacerbation Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Airway inflammatory cell compounds in smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 798s Year: 2006 Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Functional correlations between bronchial brush-biopsy composition and proteinases and its inhibitors in sputum in smokers and nonsmokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 578s Year: 2006 The cellular composition and macrophage phenotypes in induced sputum in smokers and ex-smokers with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Bronchial biopsies composition in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Bronchial biopsies cells count in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Expression of elastolytic proteases in lung parenchyma from COPD compared to normal subjects and healthy smokers Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003 Lung cancer occurrence in never smokers Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Deposition of aerosols in the lung periphery of patients with lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001